Synthes sues Stryker for 'raiding' sales force, misappropriation of secrets

A Synthes ($SYST) unit is accusing rival Stryker ($SYK) of raiding its San Francisco-based sales force and using confidential information from those ex-employees to its advantage.

In a complaint filed in a Philadelphia court, Synthes says three of its former sales employees misappropriated trade secrets and breached their contractual and fiduciary obligations. The employees resigned this year and immediately went to work for Stryker. They are now actively soliciting former customers, Bloomberg cites the filing as saying.

Through its actions, Stryker is attempting to "an improper competitive advantage" in the industry for medical implants and instruments used in spinal surgery, Synthes alleges.

Kalamazoo, MI-based Stryker didn't immediately respond to Bloomberg's requests for comment on the suit.

- get more from Bloomberg

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.